OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emma Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Annals of Neurology (2021) Vol. 91, Iss. 1, pp. 89-100
Open Access | Times Cited: 143
Showing 1-25 of 143 citing articles:
Autoimmune Encephalitis Misdiagnosis in Adults
Eoin P. Flanagan, Michael D. Geschwind, A. Sebastian López‐Chiriboga, et al.
JAMA Neurology (2022) Vol. 80, Iss. 1, pp. 30-30
Open Access | Times Cited: 151
Eoin P. Flanagan, Michael D. Geschwind, A. Sebastian López‐Chiriboga, et al.
JAMA Neurology (2022) Vol. 80, Iss. 1, pp. 30-30
Open Access | Times Cited: 151
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 111
Luuk Wieske, Koos P J van Dam, Maurice Steenhuis, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 5, pp. e338-e350
Open Access | Times Cited: 111
Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine–induced antibody and T cell immunity and function
Joseph J. Sabatino, Kristen Mittl, William Rowles, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 75
Joseph J. Sabatino, Kristen Mittl, William Rowles, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 75
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy
Maria Pia Sormani, Irene Schiavetti, Matilde Inglese, et al.
EBioMedicine (2022) Vol. 80, pp. 104042-104042
Open Access | Times Cited: 70
Maria Pia Sormani, Irene Schiavetti, Matilde Inglese, et al.
EBioMedicine (2022) Vol. 80, pp. 104042-104042
Open Access | Times Cited: 70
The Multifaceted Role of Tissue-Resident Memory T Cells
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 16
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 16
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients
Simeon Schietzel, Manuel Anderegg, Andreas Limacher, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002036-e002036
Open Access | Times Cited: 66
Simeon Schietzel, Manuel Anderegg, Andreas Limacher, et al.
RMD Open (2022) Vol. 8, Iss. 1, pp. e002036-e002036
Open Access | Times Cited: 66
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
Xi Wu, Lu Wang, Lu Shen, et al.
EBioMedicine (2022) Vol. 81, pp. 104102-104102
Open Access | Times Cited: 51
Xi Wu, Lu Wang, Lu Shen, et al.
EBioMedicine (2022) Vol. 81, pp. 104102-104102
Open Access | Times Cited: 51
Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity
Martin Scurr, George Lippiatt, Lorenzo Capitani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Martin Scurr, George Lippiatt, Lorenzo Capitani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Vaccination and immunotherapies in neuroimmunological diseases
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
Alexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 5, pp. 289-306
Open Access | Times Cited: 42
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies
Irene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 13, pp. 2106-2111
Open Access | Times Cited: 38
Irene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 13, pp. 2106-2111
Open Access | Times Cited: 38
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 8, pp. 904-925
Open Access | Times Cited: 29
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 8, pp. 904-925
Open Access | Times Cited: 29
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25
An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
Laura Dumitrescu, Αθανάσιος Παπαθανασίου, Catalina Coclitu, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 4, pp. 495-509
Open Access | Times Cited: 23
Laura Dumitrescu, Αθανάσιος Παπαθανασίου, Catalina Coclitu, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 4, pp. 495-509
Open Access | Times Cited: 23
Impact of aging on treatment considerations for multiple sclerosis patients
Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 21
Gabrielle Macaron, Catherine Larochelle, Nathalie Arbour, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 21
B Cell Depletion and SARS‐CoV ‐2 Vaccine Responses in Neuroimmunologic Patients
Barbara Kornek, Fritz Leutmezer, Paulus Rommer, et al.
Annals of Neurology (2022) Vol. 91, Iss. 3, pp. 342-352
Open Access | Times Cited: 36
Barbara Kornek, Fritz Leutmezer, Paulus Rommer, et al.
Annals of Neurology (2022) Vol. 91, Iss. 3, pp. 342-352
Open Access | Times Cited: 36
Safety and humoral response rate of inactivated and mRNA vaccines against SARS-CoV-2 in patients with Multiple Sclerosis
Ethel Ciampi, Reinaldo Uribe-San-Martín, Bernardita Soler, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103690-103690
Open Access | Times Cited: 33
Ethel Ciampi, Reinaldo Uribe-San-Martín, Bernardita Soler, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 59, pp. 103690-103690
Open Access | Times Cited: 33
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 9, pp. 986-994
Open Access | Times Cited: 33
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 9, pp. 986-994
Open Access | Times Cited: 33
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines
Ruth Dobson, David Rog, Caroline Ovadia, et al.
Practical Neurology (2022) Vol. 23, Iss. 1, pp. 6-14
Open Access | Times Cited: 31
Ruth Dobson, David Rog, Caroline Ovadia, et al.
Practical Neurology (2022) Vol. 23, Iss. 1, pp. 6-14
Open Access | Times Cited: 31
Rituximab‐treated patients with lymphoma develop strong CD8 T‐cell responses following COVID ‐19 vaccination
Jon Riise, Saskia Meyer, Isaac Blaas, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 697-708
Open Access | Times Cited: 30
Jon Riise, Saskia Meyer, Isaac Blaas, et al.
British Journal of Haematology (2022) Vol. 197, Iss. 6, pp. 697-708
Open Access | Times Cited: 30
Tixagevimab and Cilgavimab (Evusheld) boosts antibody levels to SARS-CoV-2 in patients with multiple sclerosis on b-cell depleters
William L. Conte, Lilian Golzarri‐Arroyo
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103905-103905
Open Access | Times Cited: 28
William L. Conte, Lilian Golzarri‐Arroyo
Multiple Sclerosis and Related Disorders (2022) Vol. 63, pp. 103905-103905
Open Access | Times Cited: 28
Ocrelizumab Impairs the Phenotype and Function of Memory CD8 + T Cells
Amandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 18
Amandine Mathias, Vasiliki Pantazou, Sylvain Perriot, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 2
Open Access | Times Cited: 18
Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate
Marcin Bazylewicz, Monika Zajkowska, Monika Gudowska-Sawczuk, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 153-153
Open Access
Marcin Bazylewicz, Monika Zajkowska, Monika Gudowska-Sawczuk, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 153-153
Open Access
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2144-2176
Open Access | Times Cited: 12
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 8, pp. 2144-2176
Open Access | Times Cited: 12
Knowledge domain and trend of disease-modifying therapies for multiple sclerosis: A study based on CiteSpace
Ting Zheng, Taotao Jiang, Zilong Huang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26173-e26173
Open Access | Times Cited: 4
Ting Zheng, Taotao Jiang, Zilong Huang, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26173-e26173
Open Access | Times Cited: 4
Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis
Masoud Etemadifar, Hosein Nouri, Mohammad Reza Maracy, et al.
Revue Neurologique (2021) Vol. 178, Iss. 1-2, pp. 121-128
Open Access | Times Cited: 29
Masoud Etemadifar, Hosein Nouri, Mohammad Reza Maracy, et al.
Revue Neurologique (2021) Vol. 178, Iss. 1-2, pp. 121-128
Open Access | Times Cited: 29
